期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

环孢素与伊曲康唑血药浓度相互作用研究 被引量：2

下载PDF
导出
摘要 抗真菌药物伊曲康唑与免疫抑制剂环孢素当前广泛联用以预防器官移植后免疫排斥及侵袭性真菌感染,但二者合用对彼此血药浓度有较大影响并可能威胁患者生命。本文就国内外相关的研究项目进行回顾总结,供临床合理用药参考。
作者 王非 黄显
机构地区 福建医科大学附属协和医院药学部
出处 《海峡药学》 2011年第3期12-14,共3页 Strait Pharmaceutical Journal
关键词 环孢素 三唑类抗真菌药 伊曲康唑 血药浓度 药物相互作用
分类号 R969.4 [医药卫生—药理学] F404.4 [经济管理—产业经济]
  • 相关文献

参考文献1

二级参考文献29

  • 1Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314-26.
  • 2Ohno Y, Hisaka A, Suzuki H. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Clin Pharmacokinet 2007; 46: 681-96.
  • 3Gumprecht J, Zychma M, Grzeszczak W, Kuzniewicz R, Burak W, Zywiec J, et al. Simvastatin-induced rhabdomyolysis in a CsA- treated renal transplant recipient. Med Sci Monit 2003; 9: CS89-91.
  • 4Kantola T, Kivisto KT, Neuvonen PJ. Effect of itraconazole on the pharmacokinetics of atorvastatin. Clin Pharmacol Ther 1998; 64: 58-65.
  • 5Neuvonen PJ, Kantola T, Kivisto KT. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther 1998; 63: 33241.
  • 6Neuvonen PJ, Jalava KM. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1996; 60: 54-61.
  • 7LennemPs H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Clin Pharmacokinet 1997; 32: 403-25.
  • 8Smith PF, Eydelloth RS, Grossman S J, Stubbs RJ, Schwartz MS, Germershausen JI, et al. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyelosporine A interaction and mechanism studies. J Pharmacol Exp Ther 1991; 257: 1225-35.
  • 9Ishigarni M, Kawabata K, Takasaki W, Ikeda T, Komai T, Ito K, et al. Drug interaction between simvastatin and itraconazole in male and female rats. Drug Metab Dispos 2001; 29: 1068-72.
  • 10Wierzbicki AS. Atorvastatin. Expert Opin Pharmacother 2001; 2: 819-30.

共引文献4

同被引文献19

  • 1马秉亮,吴玉林,刘国卿.P-gp及对抗P-gp介导多药耐药的研究现状[J].中国临床药理学与治疗学,2006,11(1):14-21. 被引量：15
  • 2卫生部合理用药专家委员会组织编.中国医师药师临床用药指南[M].重庆:重庆出版社,2009:231 -233;976 -978.
  • 3Licinio J,Wang ML.药物基因组学[M ].北京:科学出版社,2005:227 -233.
  • 4Lin JH, Yamazaki M. Role of P-Glycoprotein in pharmacokinetics I.l ]. Clin Pharmacokinet, 2003, 42( 1): 59-98.
  • 5Hamilton G, Cosentini EP, Teleky B, et al. The multidrug-resistance modifiers verapamil, cyclosporine A and tamoxifen induce an intracellular acidification in colon carcinoma cell lines in ~,itro [J]. Anticancer Res, 1994, 13(6A): 2059-63.
  • 6Anuchapreeda S, Leechanachai P, Smith MM, et al. Modulation of P-glyeoprotein expression and function by cureumin in multidrug- resistant human KB cells [J]. Biochem Pharmacol, 2002, 64(4): 573-82.
  • 7Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4[J]. J Pharmacol Exp Ther, 2002, 302(2): 645-50.
  • 8Nabekura TK, Kitagawa S, Effects of dietary chemopreventive phytoehemicals on p-glyeoprotein function [J]. Biochem Biophys Res Commun, 2005, 327(3): 866-70.
  • 9Shah D. A systematic evaluation of solubility enhancing excipients to enable the Generation of permeability data for poorly soluble compounds in eaco-2 model [J]. Drug Metab Lett, 2014. [in printed].
  • 10Takenaka T, Harada N, Kuze J, et al. Human small intestinal epithelial ceils differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans [J]. Drug Metab Dispos, 2014, 42(11): 1947-54.

引证文献2

二级引证文献3

海峡药学
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部